Shares of ValiRx plc (LON:VAL – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 0.25 and traded as low as GBX 0.15. ValiRx shares last traded at GBX 0.17, with a volume of 81,020,672 shares trading hands.
ValiRx Stock Performance
The stock has a market capitalization of £2.24 million, a PE ratio of -0.31 and a beta of 0.59. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.27 and a current ratio of 4.62. The firm’s 50 day moving average is GBX 0.17 and its two-hundred day moving average is GBX 0.25.
ValiRx (LON:VAL – Get Free Report) last issued its quarterly earnings results on Monday, June 22nd. The company reported GBX (0.54) EPS for the quarter. The business had revenue of GBX 3 million during the quarter. ValiRx had a negative net margin of 7,115.36% and a negative return on equity of 70.79%. As a group, research analysts predict that ValiRx plc will post -1.74 earnings per share for the current year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
